Cargando…
p62-DNA-encoding plasmid reverts tumor grade, changes tumor stroma, and enhances anticancer immunity
Previously, we reported that the administration of a p62/SQSTM1-encoding plasmid demonstrates high safety and signs of clinical benefits for human cancer patients. The treatment also suppressed tumor growth and metastasis in dogs and mouse models. Here we investigated some mechanistic aspects of the...
Autores principales: | Venanzi, Franco M., Gabai, Vladimir, Mariotti, Francesca, Magi, Gian Enrico, Vullo, Cecilia, Sufianov, Albert A., Kolesnikov, Sergey I., Shneider, Alexander |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6914433/ https://www.ncbi.nlm.nih.gov/pubmed/31754084 http://dx.doi.org/10.18632/aging.102486 |
Ejemplares similares
-
Response of a chemo-resistant triple-negative breast cancer patient to a combination of p62-encoding plasmid, Elenagen, and CMF chemotherapy
por: Ponomarenko, Dmitry M., et al.
Publicado: (2020) -
P62 plasmid can alleviate diet-induced obesity and metabolic dysfunctions
por: Halenova, Tatiana, et al.
Publicado: (2017) -
Pilot study of p62 DNA vaccine in dogs with mammary tumors
por: Gabai, Vladimir, et al.
Publicado: (2014) -
p62 /SQSTM1 coding plasmid prevents age related macular degeneration in a rat model
por: Kolosova, Nataliya G., et al.
Publicado: (2018) -
Plasmid DNA-coding p62 as a bone effective anti-inflammatory/anabolic agent
por: Sabbieti, Maria Giovanna, et al.
Publicado: (2015)